These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19193629)

  • 1. No evidence for activation of the unfolded protein response in neuronopathic models of Gaucher disease.
    Farfel-Becker T; Vitner E; Dekel H; Leshem N; Enquist IB; Karlsson S; Futerman AH
    Hum Mol Genet; 2009 Apr; 18(8):1482-8. PubMed ID: 19193629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced calcium release in the acute neuronopathic form of Gaucher disease.
    Pelled D; Trajkovic-Bodennec S; Lloyd-Evans E; Sidransky E; Schiffmann R; Futerman AH
    Neurobiol Dis; 2005 Feb; 18(1):83-8. PubMed ID: 15649698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial and temporal correlation between neuron loss and neuroinflammation in a mouse model of neuronopathic Gaucher disease.
    Farfel-Becker T; Vitner EB; Pressey SN; Eilam R; Cooper JD; Futerman AH
    Hum Mol Genet; 2011 Apr; 20(7):1375-86. PubMed ID: 21252206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression and distribution of cathepsins in neuronopathic forms of Gaucher disease and in other sphingolipidoses.
    Vitner EB; Dekel H; Zigdon H; Shachar T; Farfel-Becker T; Eilam R; Karlsson S; Futerman AH
    Hum Mol Genet; 2010 Sep; 19(18):3583-90. PubMed ID: 20616152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatidylcholine synthesis is elevated in neuronal models of Gaucher disease due to direct activation of CTP:phosphocholine cytidylyltransferase by glucosylceramide.
    Bodennec J; Pelled D; Riebeling C; Trajkovic S; Futerman AH
    FASEB J; 2002 Nov; 16(13):1814-6. PubMed ID: 12223447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An increase in ER stress and unfolded protein response in iPSCs-derived neuronal cells from neuronopathic Gaucher disease patients.
    Pornsukjantra T; Saikachain N; Sutjarit N; Khongkrapan A; Tubsuwan A; Bhukhai K; Tim-Aroon T; Anurathapan U; Hongeng S; Asavapanumas N
    Sci Rep; 2024 Apr; 14(1):9177. PubMed ID: 38649404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher's disease.
    Vitner EB; Farfel-Becker T; Eilam R; Biton I; Futerman AH
    Brain; 2012 Jun; 135(Pt 6):1724-35. PubMed ID: 22566609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of neurotrophic factors in the brain of a mouse model of Gaucher disease; implications for neuronal loss in Gaucher disease.
    Kim EY; Hong YB; Go SH; Lee B; Jung SC
    Exp Mol Med; 2006 Aug; 38(4):348-56. PubMed ID: 16953113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered intracellular redox status in Gaucher disease fibroblasts and impairment of adaptive response against oxidative stress.
    Deganuto M; Pittis MG; Pines A; Dominissini S; Kelley MR; Garcia R; Quadrifoglio F; Bembi B; Tell G
    J Cell Physiol; 2007 Jul; 212(1):223-35. PubMed ID: 17443679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal forms of Gaucher disease.
    Vitner EB; Futerman AH
    Handb Exp Pharmacol; 2013; (216):405-19. PubMed ID: 23563668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal accumulation of glucosylceramide in a mouse model of neuronopathic Gaucher disease leads to neurodegeneration.
    Farfel-Becker T; Vitner EB; Kelly SL; Bame JR; Duan J; Shinder V; Merrill AH; Dobrenis K; Futerman AH
    Hum Mol Genet; 2014 Feb; 23(4):843-54. PubMed ID: 24064337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathology provides clues to the pathophysiology of Gaucher disease.
    Wong K; Sidransky E; Verma A; Mixon T; Sandberg GD; Wakefield LK; Morrison A; Lwin A; Colegial C; Allman JM; Schiffmann R
    Mol Genet Metab; 2004 Jul; 82(3):192-207. PubMed ID: 15234332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The unfolded protein response during prostate cancer development.
    So AY; de la Fuente E; Walter P; Shuman M; Bernales S
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):219-23. PubMed ID: 19172382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoplasmic reticulum stress and the unfolded protein response.
    Kapoor A; Sanyal AJ
    Clin Liver Dis; 2009 Nov; 13(4):581-90. PubMed ID: 19818306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of catechin in type I Gaucher disease cells by reducing endoplasmic reticulum stress.
    Lee YJ; Kim SJ; Heo TH
    Biochem Biophys Res Commun; 2011 Sep; 413(2):254-8. PubMed ID: 21884680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity.
    Ron I; Horowitz M
    Hum Mol Genet; 2005 Aug; 14(16):2387-98. PubMed ID: 16000318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular responses to endoplasmic reticulum stress and apoptosis.
    Rasheva VI; Domingos PM
    Apoptosis; 2009 Aug; 14(8):996-1007. PubMed ID: 19360473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective quality control mechanisms and accumulation of damaged mitochondria link Gaucher and Parkinson diseases.
    Osellame LD; Duchen MR
    Autophagy; 2013 Oct; 9(10):1633-5. PubMed ID: 23989665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global gene expression in a type 2 Gaucher disease brain.
    Myerowitz R; Mizukami H; Richardson KL; Finn LS; Tifft CJ; Proia RL
    Mol Genet Metab; 2004 Dec; 83(4):288-96. PubMed ID: 15589115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lacidipine remodels protein folding and Ca 2+ homeostasis in Gaucher's disease fibroblasts: a mechanism to rescue mutant glucocerebrosidase.
    Wang F; Chou A; Segatori L
    Chem Biol; 2011 Jun; 18(6):766-76. PubMed ID: 21700212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.